Trial Outcomes & Findings for Paediatric Rapid Sepsis Trigger (PRST) Tool (NCT NCT04304235)
NCT ID: NCT04304235
Last Updated: 2025-05-13
Results Overview
Time in minutes to administer an appropriate antimicrobial, which includes at least one antibiotic or antimalarial (treatment determined and administered by hospital staff). The time is measured from when the child arrives at the facility (time of the first registration) until the antimicrobial administration is started.
COMPLETED
NA
18693 participants
1 day
2025-05-13
Participant Flow
Recruitment occurred at hospitals in two countries . Each country had a control and intervention site. A baseline period of data collection occurred at all sites except the control site in Uganda (due to COVID 19 pandemic restrictions). Kenya: Intervention site Baseline, Kenya Intervention site Implementation, Kenya Control site Baseline, Kenya Control site Implementation Uganda: Intervention site Baseline, Uganda Intervention site Implementation, Uganda Control site Implementation:
Non infectious illness, routine clinic visit
Participant milestones
| Measure |
Kenya Intervention Baseline
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
Kenya Intervention Implementation
Hospital nurses will triage participants using the digital triage tool (mhealth intervention).
Pediatric Rapid Sepsis Trigger (PRST) tool: The digital platform consists of a mobile application integrating a pulse oximetry sensor attached to this device, with embedded smart algorithms that predict a critically ill state, or level of risk (below) in a child presenting at the hospital. The platform also includes an interactive dashboard located in strategic locations (e.g., laboratory, consultation rooms), which connects to the mobile application through a secure local network and displays the triage data to provide real-time monitoring for the physicians who manage the patients.
|
Kenya Control Baseline
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
Kenya Control Implementation
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
Uganda Intervention Baseline
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
Uganda Intervention Implementation
Hospital nurses will triage participants using the digital triage tool (mhealth intervention).
Pediatric Rapid Sepsis Trigger (PRST) tool: The digital platform consists of a mobile application integrating a pulse oximetry sensor attached to this device, with embedded smart algorithms that predict a critically ill state, or level of risk (below) in a child presenting at the hospital. The platform also includes an interactive dashboard located in strategic locations (e.g., laboratory, consultation rooms), which connects to the mobile application through a secure local network and displays the triage data to provide real-time monitoring for the physicians who manage the patients.
|
Uganda Control Implementation
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
|---|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
2856
|
3497
|
2520
|
3177
|
1697
|
2026
|
2920
|
|
Overall Study
COMPLETED
|
2856
|
3428
|
2520
|
3177
|
1408
|
1903
|
2855
|
|
Overall Study
NOT COMPLETED
|
0
|
69
|
0
|
0
|
289
|
123
|
65
|
Reasons for withdrawal
| Measure |
Kenya Intervention Baseline
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
Kenya Intervention Implementation
Hospital nurses will triage participants using the digital triage tool (mhealth intervention).
Pediatric Rapid Sepsis Trigger (PRST) tool: The digital platform consists of a mobile application integrating a pulse oximetry sensor attached to this device, with embedded smart algorithms that predict a critically ill state, or level of risk (below) in a child presenting at the hospital. The platform also includes an interactive dashboard located in strategic locations (e.g., laboratory, consultation rooms), which connects to the mobile application through a secure local network and displays the triage data to provide real-time monitoring for the physicians who manage the patients.
|
Kenya Control Baseline
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
Kenya Control Implementation
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
Uganda Intervention Baseline
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
Uganda Intervention Implementation
Hospital nurses will triage participants using the digital triage tool (mhealth intervention).
Pediatric Rapid Sepsis Trigger (PRST) tool: The digital platform consists of a mobile application integrating a pulse oximetry sensor attached to this device, with embedded smart algorithms that predict a critically ill state, or level of risk (below) in a child presenting at the hospital. The platform also includes an interactive dashboard located in strategic locations (e.g., laboratory, consultation rooms), which connects to the mobile application through a secure local network and displays the triage data to provide real-time monitoring for the physicians who manage the patients.
|
Uganda Control Implementation
Hospital nurses will triage participants using the Emergency Triage and Treatment (ETAT) guidelines, the triage policy that is currently in place at the study hospital sites.
|
|---|---|---|---|---|---|---|---|
|
Overall Study
incomplete triage data
|
0
|
69
|
0
|
0
|
289
|
123
|
65
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Kenya Intervention Baseline
n=2856 Participants
Baseline cohort at Kenya intervention site
|
Kenya Intervention Implementation
n=3428 Participants
Implementation cohort at Kenya implementation site
|
Kenya Control Baseline
n=2520 Participants
Baseline cohort at Kenya control site
|
Kenya Control Implementation
n=3177 Participants
Implementation cohort at Kenya control site
|
Uganda Intervention Baseline
n=1408 Participants
Baseline cohort at Uganda intervention site
|
Uganda Intervention Implementation
n=1903 Participants
Implementation cohort at Uganda implementation site
|
Uganda Control Implementation
n=2855 Participants
Implementation cohort at Uganda control site
|
Total
n=18147 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|---|
|
Age, Continuous
|
25 Months
n=2856 Participants
|
31.2 Months
n=3428 Participants
|
17.55 Months
n=2520 Participants
|
13.3 Months
n=3177 Participants
|
13.55 Months
n=1408 Participants
|
15 Months
n=1903 Participants
|
17.3 Months
n=2855 Participants
|
22.4 Months
n=18147 Participants
|
|
Sex: Female, Male
Female
|
1252 Participants
n=2856 Participants
|
1466 Participants
n=3428 Participants
|
1207 Participants
n=2520 Participants
|
1504 Participants
n=3177 Participants
|
676 Participants
n=1408 Participants
|
908 Participants
n=1903 Participants
|
1418 Participants
n=2855 Participants
|
8431 Participants
n=18147 Participants
|
|
Sex: Female, Male
Male
|
1604 Participants
n=2856 Participants
|
1962 Participants
n=3428 Participants
|
1313 Participants
n=2520 Participants
|
1673 Participants
n=3177 Participants
|
732 Participants
n=1408 Participants
|
995 Participants
n=1903 Participants
|
1437 Participants
n=2855 Participants
|
9716 Participants
n=18147 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Time to antimicrobial administration
|
115 Minutes
n=2856 Participants
|
123 Minutes
n=3428 Participants
|
239 Minutes
n=2520 Participants
|
261 Minutes
n=3177 Participants
|
255 Minutes
n=1408 Participants
|
239 Minutes
n=1903 Participants
|
212 Minutes
n=2855 Participants
|
206 Minutes
n=18147 Participants
|
PRIMARY outcome
Timeframe: 1 dayPopulation: Children presenting to the outpatient department at facility
Time in minutes to administer an appropriate antimicrobial, which includes at least one antibiotic or antimalarial (treatment determined and administered by hospital staff). The time is measured from when the child arrives at the facility (time of the first registration) until the antimicrobial administration is started.
Outcome measures
| Measure |
Kenya Intervention Baseline
n=2856 Participants
Baseline cohort at Kenya intervention site
|
Kenya Intervention Implementation
n=3428 Participants
Implementation cohort at the Kenya intervention site
|
Kenya Control Baseline
n=2520 Participants
Baseline cohort at the Kenya control site
|
Kenya Control Implementation
n=3177 Participants
Implementation cohort at the Kenya control site
|
Uganda Intervention Baseline
n=1408 Participants
Baseline cohort at Uganda intervention site
|
Uganda Intervention Implementation
n=1903 Participants
Implementation cohort at the Uganda intervention site
|
Uganda Control Implementation
n=2855 Participants
Implementation cohort at Uganda control site
|
|---|---|---|---|---|---|---|---|
|
Time to Administration of an Appropriate Antimicrobial
|
115 minutes
Interval 68.0 to 203.0
|
123 minutes
Interval 68.0 to 213.0
|
239 minutes
Interval 160.0 to 388.0
|
261 minutes
Interval 193.0 to 392.0
|
255 minutes
Interval 186.0 to 348.0
|
239 minutes
Interval 171.0 to 303.0
|
212 minutes
Interval 129.0 to 295.0
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 7 daysPopulation: All participants
The child is readmitted to the hospital after being discharged
Outcome measures
| Measure |
Kenya Intervention Baseline
n=4264 Participants
Baseline cohort at Kenya intervention site
|
Kenya Intervention Implementation
n=8552 Participants
Implementation cohort at the Kenya intervention site
|
Kenya Control Baseline
n=5331 Participants
Baseline cohort at the Kenya control site
|
Kenya Control Implementation
Implementation cohort at the Kenya control site
|
Uganda Intervention Baseline
Baseline cohort at Uganda intervention site
|
Uganda Intervention Implementation
Implementation cohort at the Uganda intervention site
|
Uganda Control Implementation
Implementation cohort at Uganda control site
|
|---|---|---|---|---|---|---|---|
|
Readmission
|
57 Participants
|
57 Participants
|
48 Participants
|
—
|
—
|
—
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 7 daysPopulation: All participants
Death within 7 days
Outcome measures
| Measure |
Kenya Intervention Baseline
n=4264 Participants
Baseline cohort at Kenya intervention site
|
Kenya Intervention Implementation
n=8552 Participants
Implementation cohort at the Kenya intervention site
|
Kenya Control Baseline
n=5331 Participants
Baseline cohort at the Kenya control site
|
Kenya Control Implementation
Implementation cohort at the Kenya control site
|
Uganda Intervention Baseline
Baseline cohort at Uganda intervention site
|
Uganda Intervention Implementation
Implementation cohort at the Uganda intervention site
|
Uganda Control Implementation
Implementation cohort at Uganda control site
|
|---|---|---|---|---|---|---|---|
|
Mortality
|
39 Participants
|
23 Participants
|
14 Participants
|
—
|
—
|
—
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 12 hoursPopulation: All enrolled children
Admission to hospital
Outcome measures
| Measure |
Kenya Intervention Baseline
n=4264 Participants
Baseline cohort at Kenya intervention site
|
Kenya Intervention Implementation
n=8552 Participants
Implementation cohort at the Kenya intervention site
|
Kenya Control Baseline
n=5331 Participants
Baseline cohort at the Kenya control site
|
Kenya Control Implementation
Implementation cohort at the Kenya control site
|
Uganda Intervention Baseline
Baseline cohort at Uganda intervention site
|
Uganda Intervention Implementation
Implementation cohort at the Uganda intervention site
|
Uganda Control Implementation
Implementation cohort at Uganda control site
|
|---|---|---|---|---|---|---|---|
|
Admission
|
581 Participants
|
474 Participants
|
452 Participants
|
—
|
—
|
—
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 12 hoursPopulation: All participants.
The clinical diagnosis for each participant
Outcome measures
| Measure |
Kenya Intervention Baseline
n=567 Participants
Baseline cohort at Kenya intervention site
|
Kenya Intervention Implementation
n=472 Participants
Implementation cohort at the Kenya intervention site
|
Kenya Control Baseline
n=451 Participants
Baseline cohort at the Kenya control site
|
Kenya Control Implementation
Implementation cohort at the Kenya control site
|
Uganda Intervention Baseline
Baseline cohort at Uganda intervention site
|
Uganda Intervention Implementation
Implementation cohort at the Uganda intervention site
|
Uganda Control Implementation
Implementation cohort at Uganda control site
|
|---|---|---|---|---|---|---|---|
|
Clinical Diagnosis
Other
|
161 Participants
|
123 Participants
|
123 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Malaria
|
131 Participants
|
100 Participants
|
85 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Pneumonia
|
139 Participants
|
154 Participants
|
104 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Broncholitis
|
3 Participants
|
5 Participants
|
2 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Diarrhea/ Gastro
|
15 Participants
|
12 Participants
|
12 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Meningitis
|
11 Participants
|
6 Participants
|
5 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Malnutrition
|
17 Participants
|
5 Participants
|
8 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Septicemia
|
58 Participants
|
23 Participants
|
75 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Neonatal sepsis
|
12 Participants
|
32 Participants
|
17 Participants
|
—
|
—
|
—
|
—
|
|
Clinical Diagnosis
Dehydration
|
20 Participants
|
12 Participants
|
20 Participants
|
—
|
—
|
—
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 7 daysLength of stay in hospital for admitted cases
Outcome measures
| Measure |
Kenya Intervention Baseline
n=581 Participants
Baseline cohort at Kenya intervention site
|
Kenya Intervention Implementation
n=474 Participants
Implementation cohort at the Kenya intervention site
|
Kenya Control Baseline
n=452 Participants
Baseline cohort at the Kenya control site
|
Kenya Control Implementation
Implementation cohort at the Kenya control site
|
Uganda Intervention Baseline
Baseline cohort at Uganda intervention site
|
Uganda Intervention Implementation
Implementation cohort at the Uganda intervention site
|
Uganda Control Implementation
Implementation cohort at Uganda control site
|
|---|---|---|---|---|---|---|---|
|
Length of Stay
|
4 Days
Interval 2.0 to 7.0
|
4 Days
Interval 3.0 to 6.0
|
4 Days
Interval 2.0 to 6.0
|
—
|
—
|
—
|
—
|
POST_HOC outcome
Timeframe: 24 hoursPopulation: Participants admitted to hospital
Number cases receiving antimicrobials in the cohort of admitted cases
Outcome measures
| Measure |
Kenya Intervention Baseline
n=581 Participants
Baseline cohort at Kenya intervention site
|
Kenya Intervention Implementation
n=474 Participants
Implementation cohort at the Kenya intervention site
|
Kenya Control Baseline
n=452 Participants
Baseline cohort at the Kenya control site
|
Kenya Control Implementation
Implementation cohort at the Kenya control site
|
Uganda Intervention Baseline
Baseline cohort at Uganda intervention site
|
Uganda Intervention Implementation
Implementation cohort at the Uganda intervention site
|
Uganda Control Implementation
Implementation cohort at Uganda control site
|
|---|---|---|---|---|---|---|---|
|
Number of Intravenous Antimicrobials in Admitted Cases
|
512 Participants
|
361 Participants
|
406 Participants
|
—
|
—
|
—
|
—
|
Adverse Events
Kenya Intervention Baseline
Kenya Intervention Implementation
Kenya Control Baseline
Kenya Control Implementation
Uganda Intervention Baseline
Uganda Intervention Implementation
Uganda Control Implementation
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place